Conditioned medium of adipose derived Mesenchymal Stem Cells reverse insulin resistance through downregulation of stress induced serine kinases.
This study identifies SISK as potential therapeutic targets for T2DM therapy.
PMID: 32473166 [PubMed - as supplied by publisher]
Source: European Journal of Pharmacology - Category: Drugs & Pharmacology Authors: Sanap A, Bhonde R, Joshi K Tags: Eur J Pharmacol Source Type: research
More News: Diabetes | Diabetes Mellitus | Diabetes Type 2 | Drugs & Pharmacology | Endocrinology | Insulin | Stem Cell Therapy | Stem Cells | Study